ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2026
Frailty and neuropathy in chemotherapy patients: moderated mediation roles of fatigue and mindfulness on CIPN, anxiety, and depression.
Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Influencing factors of cognitive frailty in older patients with esophageal cancer undergoing chemotherapy: a mixed-methods study.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo examine how frailty influences chemotherapy-induced peripheral neuropathy (CIPN) and psychological distress (anxiety and depression) in chemotherapy patients, exploring the mediating role of fatigue and the moderating (protective) role of mindfulness.
methodsA cross-sectional survey enrolled 445 chemotherapy patients from three tertiary hospitals in China during April 2024-February 2025. Participants completed validated measures including the Treatment-Induced Neuropathy Assessment Scale (TNAS), Tilburg Frailty Indicator (TFI), Cancer Fatigue Scale (CFS), Freiburg Mindfulness Inventory (FMI), and Hospital Anxiety and Depression Scale (HADS). Moderated mediation analyses were conducted using structural equation modeling (SEM) with bootstrap techniques.
resultsFrailty significantly predicted higher CIPN symptoms (β = 0.179, 95% CI [0.101, 0.032]) and anxiety/depression (β = 0.216, 95% CI [0.140, 0.289]). Fatigue significantly mediated these relationships, with indirect effects of frailty on CIPN symptoms (β = 0.125, 95% CI [0.081, 0.179], accounting for 41.1% of total effect) and on anxiety/depression (β = 0.116, 95% CI [0.076, 0.163], accounting for 34.9% of total effect). Mindfulness moderated the association between frailty and fatigue (β = -0.106, 95% CI [-0.260, 0.006]) and between frailty and anxiety/depression (β = -0.083, 95% CI [-0.187, -0.005]); however, mindfulness did not significantly moderate fatigue-CIPN pathways (β = 0.022, 95% CI [-0.048, 0.089]).
conclusionFatigue is a critical mediator linking frailty to CIPN and psychological distress. Mindfulness effectively buffers the negative impacts of frailty on fatigue and psychological distress. Integrating frailty assessment, targeted fatigue management, and mindfulness interventions into clinical practice may enhance symptom management and psychological well-being among chemotherapy patients.
Indexed as
Identifiers
41586905What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.